[(5-methylfuran-2-yl)methyl](prop-2-en-1-yl)amine hydrochloride, 95.0%, 1g

9-Phenylanthracene, 95.0%, 25g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido[2,3-b]pyrazine, 95+%, 250mg

N-Boc-N-isopropylamino-acetic acid, 98.0%, 5g

2-Chloropyridine-4-boronic acid, 96.0%, 5g

2-bromo-N-(3,4-dichlorophenyl)acetamide, 250mg

5-Chloro-7-methoxythieno[3,2-b]pyridine, 97.0%, 5g

3-Biphenyl-4-yl-3-oxopropionic acid ethyl ester, 500mg

5-Ethylindole, 95.0%, 250mg

n-Hexane, min.95%, pour la synthèse, 100 ml, emballage en verre

3-(N-Boc-N-Propylamino)phenylboronic acid, 98%, 100mg

3-Bromo-4-(propan-2-yloxy)aniline hydrochloride, 95%, 100g

(4-(N,N-diethylsulfamoyl)-3,5-dimethylphenyl)boronic acid, 98%, 250mg